Literature DB >> 30188758

The Burden of Silicosis in Michigan: 1988-2016.

Mary Jo Reilly1, Suzanne J Timmer2, Kenneth D Rosenman1.   

Abstract

RATIONALE: Exposure to respirable crystalline silica causes silicosis, a preventable, progressive occupational lung disease. A more rigorous occupational health standard for silica could help protect silica-exposed workers.
OBJECTIVES: To describe trends over 29 years of silicosis surveillance in Michigan.
METHODS: Michigan law requires the reporting of silicosis. We confirmed the diagnosis of silicosis in reported cases using medical questionnaires, review of medical records, and chest radiographs. The Michigan Occupational Safety and Health Administration (OSHA) conducted enforcement inspections at the workplaces of the silicosis cases, including air monitoring for silica and evaluation of workplace medical surveillance programs.
RESULTS: The Michigan surveillance program identified 1,048 silicosis cases from 1988 to 2016, which decreased from 620 during 1988-1997, to 292 during 1998-2007, to 136 during 2008-2016. The cumulative incidence rate of silicosis decreased from 3.7 to 1.4 to 0.7 cases per 100,000 men 40 years of age and older in Michigan over the same three periods. African Americans had a higher cumulative incidence rate of silicosis, with 6.0 cases per 100,000 African American men 40 years of age and older in Michigan compared with 1.2 cases per 100,000 white men 40 years of age and older in Michigan. The cases identified had severe disease; 59% had progressive massive fibrosis or category 2 or 3 small opacities per B-reading classification of the chest radiograph. Seventeen percent reported ever having active tuberculosis. On spirometry, 76% of ever smokers and 72% of never smokers demonstrated either a restrictive or an obstructive pattern. Most (65%) had not applied for workers' compensation benefits; the percentage who applied for benefits decreased from 42% to 28-16% over the three periods. Thirty-four of 55 (62%) workplace inspections found exposures above the new OSHA 50 μg/m3 respirable crystalline silica permissible exposure limit, and only 11% of inspected companies screened their workers for silicosis.
CONCLUSIONS: Adults with confirmed cases of silicosis have advanced disease and morbidity. Most are not using workers' compensation to pay for their care. The new OSHA silica standard, which lowers the permissible exposure limit for silica and requires medical monitoring to identify workers with silicosis, will help reduce the burden of silica exposure. It is critical for pulmonologists to be vigilant to recognize and manage this preventable occupational lung disease.

Entities:  

Keywords:  chronic obstructive pulmonary disease; silica; silicosis; surveillance; tuberculosis

Mesh:

Year:  2018        PMID: 30188758      PMCID: PMC6787555          DOI: 10.1513/AnnalsATS.201802-117OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  18 in total

1.  Highway repair: a new silicosis threat.

Authors:  David J Valiante; Donald P Schill; Kenneth D Rosenman; Edward Socie
Journal:  Am J Public Health       Date:  2004-05       Impact factor: 9.308

Review 2.  The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis.

Authors:  José A Gómez-Puerta; Lydia Gedmintas; Karen H Costenbader
Journal:  Autoimmun Rev       Date:  2013-06-29       Impact factor: 9.754

3.  Mortality among persons with silicosis reported to disease surveillance systems in Michigan and New Jersey in the United States.

Authors:  K D Rosenman; M J Stanbury; M J Reilly
Journal:  Scand J Work Environ Health       Date:  1995       Impact factor: 5.024

Review 4.  Silica, silicosis and tuberculosis.

Authors:  D Rees; J Murray
Journal:  Int J Tuberc Lung Dis       Date:  2007-05       Impact factor: 2.373

5.  One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure.

Authors:  Kyle Steenland
Journal:  Am J Ind Med       Date:  2005-07       Impact factor: 2.214

6.  Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis.

Authors:  Ashima Makol; Mary Jo Reilly; Kenneth D Rosenman
Journal:  Am J Ind Med       Date:  2010-10-18       Impact factor: 2.214

7.  Silicosis in the 1990s.

Authors:  K D Rosenman; M J Reilly; D J Kalinowski; F C Watt
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

8.  Estimating the total number of newly-recognized silicosis cases in the United States.

Authors:  Kenneth D Rosenman; Mary Jo Reilly; Paul K Henneberger
Journal:  Am J Ind Med       Date:  2003-08       Impact factor: 2.214

9.  Silicosis, chronic airflow limitation, and chronic bronchitis in South African gold miners.

Authors:  R L Cowie; S K Mabena
Journal:  Am Rev Respir Dis       Date:  1991-01

10.  Notes from the field: silicosis in a countertop fabricator - Texas, 2014.

Authors:  Gary K Friedman; Robert Harrison; Heidi Bojes; Karen Worthington; Margaret Filios
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-13       Impact factor: 17.586

View more
  7 in total

1.  Silicosis prevalence and incidence among Medicare beneficiaries.

Authors:  Megan L Casey; Jacek M Mazurek
Journal:  Am J Ind Med       Date:  2019-01-18       Impact factor: 2.214

2.  Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway.

Authors:  Nannan Li; Ke Wu; Feifei Feng; Lin Wang; Xiang Zhou; Wei Wang
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

3.  Secondary prevention of silicosis and silico-tuberculosis by periodic screening of silica dust exposed workers using serum club cell protein 16 as a proxy marker.

Authors:  Kamalesh Sarkar; Sarang Dhatrak; Bidisa Sarkar; Umesh Chandra Ojha; Pankaja Raghav; Avinash Pagdhune
Journal:  Health Sci Rep       Date:  2021-09-22

4.  Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis.

Authors:  Jeremy Tang Hua; Lauren Zell-Baran; Leonard H T Go; Mordechai R Kramer; Johanna B Van Bree; Daniel Chambers; David Deller; Katrina Newbigin; Michael Matula; Elizabeth Fireman; Mor Dahbash; Cristina Martinez-Gonzalez; Antonio León-Jimenez; Coralynn Sack; Jaume Ferrer; Ana Villar; Kirsten S Almberg; Robert A Cohen; Cecile S Rose
Journal:  Occup Environ Med       Date:  2022-05-03       Impact factor: 4.948

5.  Causes of death among Federal Black Lung Benefits Program beneficiaries enrolled in Medicare, 1999-2016.

Authors:  Laura Kurth; Cara Halldin; A Scott Laney; David J Blackley
Journal:  Am J Ind Med       Date:  2020-09-11       Impact factor: 3.079

6.  The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation.

Authors:  Feifei Feng; Peng Cheng; Huanan Zhang; Nannan Li; Yuxin Qi; Hui Wang; Yongbin Wang; Wei Wang
Journal:  Drug Des Devel Ther       Date:  2019-12-18       Impact factor: 4.162

7.  Silicosis, progressive massive fibrosis and silico-tuberculosis among workers with occupational exposure to silica dusts in sandstone mines of Rajasthan state: An urgent need for initiating national silicosis control programme in India.

Authors:  Subroto S Nandi; Sarang V Dhatrak; Kamalesh Sarkar
Journal:  J Family Med Prim Care       Date:  2021-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.